序号 |
标题 |
次数 |
作者 |
发布时间 |
83296 |
黄芩甙-羟丙基-β-环糊精包合物 Baicalin-HP-β-CD |
171 |
h |
2024-11-27 |
83297 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz)乙二胺盐(EDA·BTATz) |
131 |
WYQ |
2024-11-27 |
83298 |
G5.NHAc-FITC-PEG-FA/TOS , 五代聚酰胺胺树状大分子修饰异硫氰酸荧光素聚乙二醇化药物alpha-维生素e琥珀酸酯 |
198 |
kx |
2024-11-27 |
83299 |
小檗碱-β-环糊精包合物 berbine-β-CD |
119 |
h |
2024-11-27 |
83300 |
DOTA-Octreotide,DOTA-奥曲肽,基于NOTADOTA定制和偶联 |
92 |
zcy |
2024-11-27 |
83301 |
Ac-mPEG-DOTA(Gd) , mPEG修饰钆螯合剂(DOTA) |
102 |
kx |
2024-11-27 |
83302 |
DOTA-Phe-Tyr-Leu-Glu-His-Pro-Ser-Gly-Gly-Leu-Ala-Val-COOH |
153 |
zyl |
2024-11-27 |
83303 |
DOTA-MeTz,1610950-41-8,DOTA-甲基四嗪 |
87 |
zcy |
2024-11-27 |
83304 |
CREKA-(Gd-DOTA)4 ,Gd-DOTA修饰靶向纤维蛋白-纤维连接蛋白复合物 |
119 |
kx |
2024-11-27 |
83305 |
DOTA-PEG-DSPE/OPSS 大环配体-聚乙二醇-磷脂 |
87 |
zcy |
2024-11-27 |
83306 |
DOTA-lysFA , 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-赖氨酸-叶酸 DOTA-lys-FA |
80 |
kx |
2024-11-27 |
83307 |
DOTA-RGD,DOTA-cRGDfK |
159 |
zyl |
2024-11-27 |
83308 |
DOTA-(Tyr³)-Octreotide acetate salt-Somatostatin |
91 |
zyl |
2024-11-27 |
83309 |
DOTA Ala COOH(1248343-67-0) |
97 |
zcy |
2024-11-27 |
83310 |
DOTARGD2 DOTA-RGD2; 1,4,7,10一四氮杂环十二烷-l,4,7,10-四乙酸-(精氨酸-甘氨酸-天冬氨酸)2 |
89 |
kx |
2024-11-27 |
83311 |
姜黄素磺丁基醚-β-环糊精包合物 CUR-SBE-β-CD |
142 |
h |
2024-11-27 |
83312 |
6-(3,5-二甲基-1H-吡唑)-1,2,4,5-四嗪-3-胍盐(G·DPTzO) |
94 |
WYQ |
2024-11-27 |
83313 |
DOTA-NOC acetate,619300-53-7 |
93 |
zcy |
2024-11-27 |
83314 |
丁香挥发油β-环糊精包合物 |
190 |
h |
2024-11-27 |
83315 |
Acp-DOTA-Gd , 金属离子DOTA螯合剂 |
150 |
kx |
2024-11-27 |
83316 |
6-(3,5-二甲基-1H-吡唑)-1,2,4,5-四嗪-3-钾盐(K·DPTzO) |
98 |
WYQ |
2024-11-27 |
83317 |
六氢四嗪-1,2,4,5-四甲酸酯类化合物 |
107 |
WYQ |
2024-11-27 |
83318 |
DOTA-PEG-CY7 ,大环化合物DOTA标记荧光染料 |
81 |
zyl |
2024-11-27 |
83319 |
环糊精药物包合物 |
154 |
h |
2024-11-27 |
83320 |
聚乙烯醇固载β-环糊精 PVA-β-CD |
91 |
h |
2024-11-27 |
83321 |
Ad-PG-g-s-s-DOTA(Gd) , 金刚烷甲醇-聚缩水甘油偶联叠氮修饰的DOTA钆配合物 |
73 |
kx |
2024-11-27 |
83322 |
DOTA-cRGDfK,DOTA-RGD 大环化合物DOTA-多肽 |
78 |
zyl |
2024-11-27 |
83323 |
线性双羟基聚合物OH-PEEGE-OH |
120 |
kx |
2024-11-27 |
83324 |
聚乙烯亚胺-β-环糊精负载5-氟尿嘧啶 5-FU/PEI-β-CD |
149 |
h |
2024-11-27 |
83325 |
寡聚(p-苯撑乙炔)分子上修饰四嗪功能基团 |
153 |
WYQ |
2024-11-27 |
83326 |
两嵌段共聚物mPEG-PEEGE-b-PCL |
122 |
kx |
2024-11-27 |
83327 |
Gd-DOTA-Peptide |
111 |
zyl |
2024-11-27 |
83328 |
2.3-O-异丙基烯丙基醚基-2,6-二-O-戊基-β-环糊精接枝聚硅氧烷 |
83 |
h |
2024-11-27 |
83329 |
3,6-双(氨基硝基胍基)-1,2,4,5-四嗪(BANTz) |
84 |
WYQ |
2024-11-27 |
83330 |
HSA-GGD-ICG ,人血清白蛋白-GGD-吲哚菁绿 |
116 |
kx |
2024-11-27 |
83331 |
β-环糊精-聚乙二醇单甲醚-聚乳酸 sPEL/CDs |
106 |
h |
2024-11-27 |
83332 |
3-(氨基硝基胍基)-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(ANPTz) |
87 |
WYQ |
2024-11-27 |
83333 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz)离子盐 |
101 |
WYQ |
2024-11-27 |
83334 |
DOTA mono-NHS ester,170908-81-3 羟基琥珀酰亚胺-四氮杂环十二烷四乙酸 |
131 |
zyl |
2024-11-27 |
83335 |
NTR激活MRI造影剂Gd-DOTA-PNB |
117 |
kx |
2024-11-27 |
83336 |
环糊精/聚丙烯酸/聚乙二醇三元复合物 β-CD/PAA/PEG |
88 |
h |
2024-11-27 |
83337 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮钾盐(K2·TATzO) |
85 |
WYQ |
2024-11-27 |
83338 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮(TATzO) |
109 |
WYQ |
2024-11-27 |
83339 |
DOTA-Octreotide;放射性示踪剂;大环配体多肽 |
81 |
zcy |
2024-11-27 |
83340 |
Gd-DOTA-E-[c(RGDf K)]2 , Gd-DOTA修饰靶向双环肽E-[c(R GDf K)]2 |
94 |
kx |
2024-11-27 |